These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 23470567

  • 1. Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene.
    Takase S, Osuga J, Fujita H, Hara K, Sekiya M, Igarashi M, Takanashi M, Takeuchi Y, Izumida Y, Ohta K, Kumagai M, Nishi M, Kubota M, Masuda Y, Taira Y, Okazaki S, Iizuka Y, Yahagi N, Ohashi K, Yoshida H, Yanai H, Tada N, Gotoda T, Ishibashi S, Kadowaki T, Okazaki H.
    J Atheroscler Thromb; 2013; 20(5):481-93. PubMed ID: 23470567
    [Abstract] [Full Text] [Related]

  • 2. A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis.
    Ueda M, Dunbar RL, Wolska A, Sikora TU, Escobar MDR, Seliktar N, deGoma E, DerOhannessian S, Morrell L, McIntyre AD, Burke F, Sviridov D, Amar M, Shamburek RD, Freeman L, Hegele RA, Remaley AT, Rader DJ.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1454-1457. PubMed ID: 28201738
    [Abstract] [Full Text] [Related]

  • 3. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.
    Sakurai T, Sakurai A, Vaisman BL, Amar MJ, Liu C, Gordon SM, Drake SK, Pryor M, Sampson ML, Yang L, Freeman LA, Remaley AT.
    J Pharmacol Exp Ther; 2016 Feb 01; 356(2):341-53. PubMed ID: 26574515
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency.
    Okubo M, Toromanovic A, Ebara T, Murase T.
    Clin Chim Acta; 2015 Jan 01; 438():148-53. PubMed ID: 25172036
    [Abstract] [Full Text] [Related]

  • 5. Severe hyperchylomicronemia in two infants with novel APOC2 gene mutation.
    Kose E, Armagan C, Teke Kısa P, Onay H, Arslan N.
    J Pediatr Endocrinol Metab; 2018 Nov 27; 31(11):1289-1293. PubMed ID: 30307897
    [Abstract] [Full Text] [Related]

  • 6. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.
    Stalenhoef AF, Casparie AF, Demacker PN, Stouten JT, Lutterman JA, van 't Laar A.
    Metabolism; 1981 Sep 27; 30(9):919-26. PubMed ID: 7266379
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.
    Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, Sviridov DO, Remaley AT.
    Atherosclerosis; 2017 Dec 27; 267():49-60. PubMed ID: 29100061
    [Abstract] [Full Text] [Related]

  • 8. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
    Buonuomo PS, Rabacchi C, Macchiaiolo M, Trenti C, Fasano T, Tarugi P, Bartuli A, Bertolini S, Calandra S.
    J Clin Lipidol; 2017 Dec 27; 11(6):1329-1337.e3. PubMed ID: 28951076
    [Abstract] [Full Text] [Related]

  • 9. Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia.
    Liu C, Gates KP, Fang L, Amar MJ, Schneider DA, Geng H, Huang W, Kim J, Pattison J, Zhang J, Witztum JL, Remaley AT, Dong PD, Miller YI.
    Dis Model Mech; 2015 Aug 01; 8(8):989-98. PubMed ID: 26044956
    [Abstract] [Full Text] [Related]

  • 10. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
    Chokshi N, Blumenschein SD, Ahmad Z, Garg A.
    J Clin Lipidol; 2014 Aug 01; 8(3):287-95. PubMed ID: 24793350
    [Abstract] [Full Text] [Related]

  • 11. Molecular and functional characterization of familial chylomicronemia syndrome.
    Teramoto R, Tada H, Kawashiri MA, Nohara A, Nakahashi T, Konno T, Inazu A, Mabuchi H, Yamagishi M, Hayashi K.
    Atherosclerosis; 2018 Feb 01; 269():272-278. PubMed ID: 29153744
    [Abstract] [Full Text] [Related]

  • 12. ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome.
    Parrott CL, Alsayed N, Rebourcet R, Santamarina-Fojo S.
    J Lipid Res; 1992 Mar 01; 33(3):361-7. PubMed ID: 1569385
    [Abstract] [Full Text] [Related]

  • 13. Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients.
    Liu C, Gaudet D, Miller YI.
    PLoS One; 2017 Mar 01; 12(1):e0169939. PubMed ID: 28107429
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
    Martín-Campos JM, Julve J, Roig R, Martínez S, Errico TL, Martínez-Couselo S, Escolà-Gil JC, Méndez-González J, Blanco-Vaca F.
    Clin Chim Acta; 2014 Feb 15; 429():61-8. PubMed ID: 24291057
    [Abstract] [Full Text] [Related]

  • 15. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ, Sakurai T, Sakurai-Ikuta A, Sviridov D, Freeman L, Ahsan L, Remaley AT.
    J Pharmacol Exp Ther; 2015 Feb 15; 352(2):227-35. PubMed ID: 25395590
    [Abstract] [Full Text] [Related]

  • 16. Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia.
    Hooper AJ, Kurtkoti J, Hamilton-Craig I, Burnett JR.
    Ann Clin Biochem; 2014 Jul 15; 51(Pt 4):485-9. PubMed ID: 24591733
    [Abstract] [Full Text] [Related]

  • 17. Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency.
    Yoldas Celik M, Canda E, Yazici H, Erdem F, Yuksel Yanbolu A, Atik Altinok Y, Pariltay E, Akin H, Kalkan Ucar S, Coker M.
    Nutr Metab Cardiovasc Dis; 2024 Jul 15; 34(7):1798-1806. PubMed ID: 38503616
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetics of apoC-II and lipoprotein lipase deficiency.
    Fojo SS, de Gennes JL, Beisiegel U, Baggio G, Stalenhoef AF, Brunzell JD, Brewer HB.
    Adv Exp Med Biol; 1991 Jul 15; 285():329-33. PubMed ID: 1858563
    [No Abstract] [Full Text] [Related]

  • 19. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J, Escolà-Gil JC, Rotllan N, Fiévet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F.
    Arterioscler Thromb Vasc Biol; 2010 Feb 15; 30(2):232-8. PubMed ID: 19910634
    [Abstract] [Full Text] [Related]

  • 20. A novel type hypertriglyceridemia observed in FLS mice.
    Takahashi M, Saibara T, Nemoto Y, Ono M, Akisawa N, Iwasaki S, Toda K, Ogawa Y, Wakatsuki A, Inagaki S, Onishi S.
    Lipids; 2003 Jul 15; 38(7):687-92. PubMed ID: 14506831
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.